Insider Selling: Liquidia (NASDAQ:LQDA) Insider Sells $60,220.64 in Stock

Posted by Francis Steltz on Aug 1st, 2026

Liquidia Corporation (NASDAQ:LQDA – Get Free Report) insider Jason Adair sold 688 shares of Liquidia stock in a transaction dated Monday, July 27th. The shares were sold at an average price of $87.53, for a total transaction of $60,220.64. Following the completion of the sale, the insider owned 216,438 shares in the company, valued at approximately $18,944,818.14. This trade represents a 0.32% decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at the SEC website. The transaction was executed under a pre-arranged Rule 10b5-1 trading plan. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Jason Adair also recently made the following trade(s):

On Monday, July 13th, Jason Adair sold 7,863 shares of Liquidia stock. The stock was sold at an average price of $71.51, for a total transaction of $562,283.13.

Liquidia Stock Down 3.1%

LQDA opened at $84.11 on Friday. The company has a market cap of $7.48 billion, a PE ratio of 600.83 and a beta of 0.55. Liquidia Corporation has a twelve month low of $16.82 and a twelve month high of $91.10. The company has a 50-day moving average price of $73.77 and a 200 day moving average price of $51.95. The company has a quick ratio of 2.03, a current ratio of 2.22 and a debt-to-equity ratio of 1.18.

Liquidia (NASDAQ:LQDA – Get Free Report) last posted its quarterly earnings data on Monday, May 11th. The company reported $0.52 earnings per share (EPS) for the quarter, topping the consensus estimate of $0.41 by $0.11. Liquidia had a return on equity of 46.82% and a net margin of 7.74%.The company had revenue of $132.87 million for the quarter, compared to analysts’ expectations of $119.44 million. Liquidia’s revenue was up 4187.1% on a year-over-year basis. Sell-side analysts expect that Liquidia Corporation will post 3.02 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Liquidia

Several hedge funds and other institutional investors have recently made changes to their positions in LQDA. Farallon Capital Management LLC lifted its position in Liquidia by 1.1% during the fourth quarter. Farallon Capital Management LLC now owns 8,656,038 shares of the company’s stock worth $298,547,000 after buying an additional 90,400 shares in the last quarter. Vanguard Group Inc. grew its holdings in Liquidia by 1.3% in the 4th quarter. Vanguard Group Inc. now owns 4,013,888 shares of the company’s stock valued at $138,439,000 after buying an additional 52,671 shares in the last quarter. Opaleye Management Inc. increased its stake in shares of Liquidia by 9.5% in the 2nd quarter. Opaleye Management Inc. now owns 2,475,000 shares of the company’s stock worth $30,838,000 after acquiring an additional 215,000 shares during the last quarter. Bank of America Corp DE increased its stake in shares of Liquidia by 18.7% in the 1st quarter. Bank of America Corp DE now owns 2,287,792 shares of the company’s stock worth $86,341,000 after acquiring an additional 360,372 shares during the last quarter. Finally, Caprock Group LLC raised its holdings in shares of Liquidia by 9.3% during the 4th quarter. Caprock Group LLC now owns 1,783,921 shares of the company’s stock worth $61,527,000 after acquiring an additional 151,832 shares during the period. Institutional investors and hedge funds own 64.54% of the company’s stock.

Wall Street Analysts Forecast Growth

Several analysts recently commented on the company. Jefferies Financial Group reiterated a “buy” rating and set a $60.00 price target on shares of Liquidia in a research report on Monday, May 11th. BTIG Research lifted their target price on shares of Liquidia from $59.00 to $109.00 and gave the stock a “buy” rating in a research note on Monday, June 22nd. Piper Sandler set a $129.00 target price on shares of Liquidia in a report on Friday, July 24th. Wells Fargo & Company increased their target price on shares of Liquidia from $51.00 to $62.00 and gave the company an “overweight” rating in a research report on Tuesday, May 12th. Finally, Raymond James Financial reissued a “strong-buy” rating and issued a $68.00 price target on shares of Liquidia in a research note on Thursday, June 4th. Three analysts have rated the stock with a Strong Buy rating, five have issued a Buy rating, one has issued a Hold rating and two have issued a Sell rating to the company. According to MarketBeat, the stock currently has an average rating of “Moderate Buy” and a consensus target price of $86.18.

View Our Latest Research Report on LQDA

About Liquidia

(Get Free Report)

Liquidia Technologies, Inc is a clinical-stage biopharmaceutical company headquartered in Research Triangle Park, North Carolina. The company leverages its proprietary PRINT® (Particle Replication In Non-wetting Templates) platform to engineer precisely shaped and sized drug particles, with the goal of improving delivery, efficacy and safety profiles. By controlling particle characteristics at the nanoscale, Liquidia seeks to enhance respiratory and other therapies that depend on targeted delivery.

The company’s lead product candidate, LIQ861, is a dry powder formulation of treprostinil designed for inhalation in patients with pulmonary arterial hypertension (PAH).